$IDXG Income Statement | Understand Stock

$IDXG

$6.91 +$0.40 (6.18%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of revenue
Gross profit
Operating expenses:
Sales and marketing
Research and development
General and administrative
Transition expense
Loss on DiamiR transaction
Acquisition related amortization expense
Change in fair value of contingent consideration
Total operating expenses

Operating income from continuing operations
Related party interest
Note payable interest
Interest accretion expense
Note payable interest expense
Other expense, net
Income from continuing operations before tax
(Benefit) provision for income taxes
Loss from continuing operations
Income from continuing operations
Loss from discontinued operations, net of tax
Net income
Less adjustment for preferred stock deemed dividend
Net income attributable to common stockholders
From continuing operations
From discontinued operations
Net loss per basic and diluted share of common stock
Basic net income (loss) per share of common stock:
From continuing operations
From discontinued operations
Net income (loss) per basic share of common stock
Diluted net income (loss) per share of common stock:
From continuing operations
From discontinued operations
Net income (loss) per diluted share of common stock
Weighted average number of common shares and common share equivalents outstanding:
Basic
Diluted

Comments